1416 Results

People

  1. Motzer
    Motzer
  2. Vickers
    Vickers
  3. Hudis
    Hudis
  4. Norton
    Norton
  5. Saltz
    Saltz
  6. O'Reilly
    O'Reilly
  7. Mao
    Mao
  8. Morris
    Morris
  9. Seidman
    Seidman
  10. Kris
    Kris

Groups

  1. Department of Medicine (753)
  2. Solid Tumor Oncology Division (541)
  3. Population Sciences Research Program (259)
  4. Survivorship Research (256)
  5. Surgery (244)
  6. Epidemiology and Biostatistics (187)
  7. Hematologic Malignancies, Division of (169)
  8. Genitourinary Oncology Service (160)
  9. Center for Hematologic Malignancies (142)
  10. Gastrointestinal Oncology Service (126)
  1. "randomized controlled trial"
Formats
  1. Journal Article (1353)
  2. Review (19)
  3. Conference Paper (17)
  4. Editorial (9)
  5. Correspondence (5)
  6. Research Letter (5)
  7. Meeting Abstract (4)
  8. Guidelines (3)
  9. Book Section (1)
Groups
  1. Department of Medicine (753)
  2. Solid Tumor Oncology Division (541)
  3. Population Sciences Research Program (259)
  4. Survivorship Research (256)
  5. Surgery (244)
  6. Epidemiology and Biostatistics (187)

More Groups

People
  1. Robert Motzer (83)
  2. Andrew Vickers (48)
  3. Larry Norton (34)
  4. Clifford Hudis (33)
  5. Leonard Saltz (32)
  6. Eileen O'Reilly (25)

More People

Years
  1. 2025 (63)
  2. 2024 (165)
  3. 2023 (110)
  4. 2022 (81)
  5. 2021 (39)
  6. 2020 (51)

More Years

Publications
  1. Journal of Clinical Oncology (164)
  2. New England Journal of Medicine (65)
  3. Lancet Oncology (46)
  4. Cancer (42)
  5. Clinical Cancer Research (42)
  6. European Urology (26)

More Publications

Publishers
  1. Elsevier Inc. (187)
  2. American Society of Clinical Oncology (170)
  3. Elsevier Science, Inc. (138)
  4. Springer (79)
  5. Lippincott Williams & Wilkins (72)
  6. Wiley Blackwell (71)

More Publishers

Results (1416)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Associations between ERBB2 amplification and progression-free survival and overall survival in advanced stage, suboptimally-resected epithelial ovarian cancers: A Gynecologic Oncology Group study
    Journal Article

    Farley, J.; Fuchiuji, S.; Darcy, K. M.; Tian, C.; Hoskins, W. J.; McGuire, W. P.; Hanjani, P.; Warshal, D.; Greer, B. E.; Belinson, J.; more...
    Gynecologic Oncology (2009)

    Fulltext@MSK | Save
  • Lower-dose vs high-dose oral estradiol therapy of hormone receptor-positive, aromatase inhibitor-resistant advanced breast cancer: A phase 2 randomized study
    Journal Article

    Ellis, M. J.; Gao, F.; Dehdashti, F.; Jeffe, D. B.; Marcom, P. K.; Carey, L. A.; Dickler, M. N.; Silverman, P.; Fleming, G. F.; Kommareddy, A.; more...
    JAMA - Journal of the American Medical Association (2009)

    Fulltext@MSK | Save
  • Efficacy and safety of erlotinib in patients with locally advanced or metastatic breast cancer
    Journal Article

    Dickler, M. N.; Cobleigh, M. A.; Miller, K. D.; Klein, P. M.; Winer, E. P.
    Breast Cancer Research and Treatment (2009)

    Fulltext@MSK | Save
  • Adjuvant imatinib mesylate after resection of localised, primary gastrointestinal stromal tumour: a randomised, double-blind, placebo-controlled trial
    Journal Article

    DeMatteo, R. P.; Ballman, K. V.; Antonescu, C. R.; Maki, R. G.; Pisters, P. W.; Demetri, G. D.; Blackstein, M. E.; Blanke, C. D.; von Mehren, M.; Brennan, M. F.; more...
    Lancet (2009)

    Fulltext@MSK | Save
  • Anaplastic glioma: How to prognosticate outcome and choose a treatment strategy
    Journal Article

    Deangelis, L. M.
    Journal of Clinical Oncology (2009)

    Fulltext@MSK | Save
  • Randomized phase II trial of chemoradiotherapy followed by either dose-dense or metronomic temozolomide for newly diagnosed glioblastoma
    Journal Article

    Clarke, J. L.; Iwamoto, F. M.; Sul, J.; Panageas, K.; Lassman, A. B.; DeAngelis, L.; Hormigo, A.; Nolan, C. P.; Gavrilovic, I.; Karimi, S.; more...
    Journal of Clinical Oncology (2009)

    Fulltext@MSK | Save
  • Addition of muramyl tripeptide to chemotherapy for patients with newly diagnosed metastatic osteosarcoma: A report from the Children's Oncology Group
    Journal Article

    Chou, A. J.; Kleinerman, E. S.; Krailo, M. D.; Chen, Z.; Betcher, D. L.; Healey, J. H.; Conrad, E. U. 3rd; Nieder, M. L.; Weiner, M. A.; Wells, R. J.; more...
    Cancer (2009)

    Fulltext@MSK | Save
  • Cytochrome P450 2C9 variants influence response to celecoxib for prevention of colorectal adenoma
    Journal Article

    Chan, A. T.; Zauber, A. G.; Hsu, M.; Breazna, A.; Hunter, D. J.; Rosenstein, R. B.; Eagle, C. J.; Hawk, E. T.; Bertagnolli, M. M.
    Gastroenterology (2009)

    Fulltext@MSK | Save
  • Quality of life predicts progression-free survival in patients with metastatic renal cell carcinoma treated with sunitinib versus interferon alfa
    Journal Article

    Cella, D.; Cappelleri, J. C.; Bushmakin, A.; Charbonneau, C.; Li, J. Z.; Kim, S. T.; Chen, I.; Michaelson, M. D.; Motzer, R. J.
    Journal of Oncology Practice (2009)

    Fulltext@MSK | Save
  • Complementary therapies, herbs, and other OTC agents: Music therapy
    Journal Article

    Cassileth, B.
    Oncology (Norwalk) (2009)

    Fulltext@MSK | Save